This new investigation from the United Kingdom evaluated health care professionals’ (HCP) perceptions and implementation of practices that focus on open-source automated insulin delivery (OS-AID).
Results of a survey conducted in the United Kingdom from February through April 2019 revealed that although health care professionals (HCPs) are aware of the benefits of open-source automated insulin delivery (OS-AID) for children and adults with type 1 diabetes, and would support patients who choose to use it, few are confident in both their overall knowledge of the technology and their awareness of its regulations and do not discuss the potential treatment option as a result.
Findings were published recently in Diabetes Therapy, and they also revealed 43% of HCPs surveyed have concerns OS-AID use may introduce risk of adverse outcomes if put “in the wrong hands.” Their survey was distributed through the Association of British Clinical Diabetologists Diabetes Technology Network UK and the Association of Children’s Diabetes Clinicians (ACDC). Questions could be answered on a Likert scale of 1 to 5, yes/no manner, or via multiple choice, which contained an option to write in their own answer.
“OS-AID systems have previously been described in detail in other papers and their uptake by the diabetes community has grown steadily over the past few years. [However,] they remain unapproved at present,” the study authors wrote. “Given the complexities of the issues around OS-AID systems from clinical, regulatory, and ethical viewpoints, the aim of this work was to establish the prevailing opinions and perceptions of HCPs and their approaches to users of these systems in everyday practice.”
Of the 317 responses received, few responded that they were “extremely confident” in being able to adequately describe how to set up an OS-AID (8.8%). On the contrary, a majority (73.5%) were “somewhat confident” or less, as indicated by a score of 3 or more on the Likert scale. Just 5 of the “extremely confident” respondents were from practices that had 5 or more patients already using an OS-AID.
Similar trends were seen when considering the risks and benefits, respectively, of OS-AID systems: Most—77.9% and 81.4%—were “somewhat confident” or less at being able to adequately address these with their patients. Just 3.7% and 5.3%, respectively, chose “extremely confident.”
Consultants were shown to be the most confident (P < .001) at being able to discuss OS-AID systems, compared with diabetes specialists, with regard to the system as a whole, risks, and benefits.
Total insulin pump and OS-AID users in a service also were likely factors in level of comfort. Pairwise comparisons demonstrated that respondents at practices with fewer than 2 OS-AID users had less confidence compared with respondents at practices with 2 to 5 or 6 to 10 users. Respondents at pump centers with 0 to 100 users had less confidence that those at centers with more than 500 insulin pump users.
Close to 91% chose a multiple-choice answer for their attitudes toward OS-AID systems and their current practice, with the majority again saying they were uncomfortable providing ongoing support (59.0%). Just 5% felt “extremely comfortable.” Most (91%) also noted they were uncomfortable even initiating discussions about OS-AID systems, with common reasons being because they were still unapproved (67%), had limited knowledge (63%), had concern for their professional reputations (31.8%), and did not want to invalidate a National Health Service–provided pump warranty (28%).
Despite the above numbers, 94% said they would still provide ongoing care; among those who said they were not able to provide care, their principal reason was feeling unable to advise on system management. Further, 96.5% expressed a belief that HCPs should learn more about OS-AID and 95.9% said they wanted to learn more themselves.
Reference
Crabtree TSJ, Choudhary P, Lumb A, et al. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children’s Diabetes Clinicians survey of UK healthcare professional attitudes towards open-source automated insulin delivery systems. Diabetes Ther. 2022;13(2):341-353. doi:10.1007/s13300-022-01203-5
Bringing Connectivity to the Specialty Pharmacy Workflow
May 2nd 2024In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized the need to simplify the prescribing workflow for specialty medication through proactive messaging, automation, and interoperability.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More